Strüngmann Brothers invest in eHealth Specialist ICW

InterComponentWare AG (ICW)Santo Holding (Germany) GmbH of Hexal founders Strüngmann secured a 25 percent share in the eHealth specialist InterComponentWare AG (ICW). This transaction was performed by the purchase of newly issued shares in the context of an increase in capital stock. The present owners of ICW do not surrender any shares in this transaction.

ICW will invest its newly acquired funds into the further expansion of its leading position in the international eHealth market. The company is one of the internationally active eHealth pioneers and offers a very broad range of solutions focusing on citizens respectively patients.

ICW pursues two strategic approaches to improve communication and thus also quality and efficiency in the health care system: First of all, it supports the introduction of ubiquitous secure health care IT infrastructures with electronic health cards and personal health records. At the beginning of 2007, ICW was awarded the pilot project for the introduction of the national electronic health card in Bulgaria. The company also conducts a field test for the electronic health card in Germany since 2005, which includes the personal health record LifeSensor. The LifeSensor technology is also applied in the BARMER research project, in which Germany's largest health insurance company will offer its approx. 7 million insurants a personal health record.

ICW's second strategic approach is to network medical professionals in medical practices and hospitals with each other. PPV, for example, a Bavarian physician's network, uses ICW solutions to give its approximately 350 members a comprehensive view of their patients' medical data. Heidelberg University Hospital also opted for a solution developed by ICW to network with its partner hospitals. This solution also incorporates patients and resident physicians into the improved data flow.

"The trust of our new investors in ICW shows that we are pursuing the right strategy and that our solutions have a large national and international market potential", explains ICW's CEO Peter Reuschel. The Strüngmann brothers are also absolutely convinced that ICW will continue to expand its position in the global eHealth market: "We opted for an investment in ICW, because it is in a perfect position to assert itself in the high-growth global eHealth market with its open platform approach and mature solutions. With its networking solutions, ICW has the potential to make the national and global health care market more efficient. We want to support and accompany this process", explain the Strüngmann brothers.

Related news articles:

About InterComponentWare
InterComponentWare AG (ICW) is a leading international eHealth specialist with locations in Germany, the United States, Austria, Switzerland and Bulgaria. Its solutions for networking the various players in the healthcare system lastingly improve process-oriented communication and data integrity, and therefore also the quality of healthcare. Among other things, ICW develops and distributes software and hardware components for the healthcare IT infrastructure for electronic health cards, the LifeSensor personal health record as well as networking solutions for hospitals and physician offices. As part of the bIT4health consortium, ICW provided important consulting services for the implementation of the electronic health card in Germany, is involved in the Austrian eCard project and has won the pilot project for the national health card in Bulgaria. For further information, visit:

Most Popular Now

Do Fitness Apps do More Harm than Good?

A study published in the British Journal of Health Psychology reveals the negative behavioral and psychological consequences of commercial fitness apps reported by users on social media. These impacts may...

AI Tool Beats Humans at Detecting Parasi…

Scientists at ARUP Laboratories have developed an artificial intelligence (AI) tool that detects intestinal parasites in stool samples more quickly and accurately than traditional methods, potentially transforming how labs diagnose...

Making Cancer Vaccines More Personal

In a new study, University of Arizona researchers created a model for cutaneous squamous cell carcinoma, a type of skin cancer, and identified two mutated tumor proteins, or neoantigens, that...

AI can Better Predict Future Risk for He…

A landmark study led by University' experts has shown that artificial intelligence can better predict how doctors should treat patients following a heart attack. The study, conducted by an international...

A New AI Model Improves the Prediction o…

Breast cancer is the most commonly diagnosed form of cancer in the world among women, with more than 2.3 million cases a year, and continues to be one of the...

AI System Finds Crucial Clues for Diagno…

Doctors often must make critical decisions in minutes, relying on incomplete information. While electronic health records contain vast amounts of patient data, much of it remains difficult to interpret quickly...